[MDGL] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -18.24%
YoY- -170.49%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -61,651 -52,546 -59,123 -57,963 -49,023 -36,135 -27,740 70.38%
Tax 0 -160 -116 0 -1,319 0 -28 -
NP -61,651 -52,546 -59,123 -57,963 -49,023 -36,135 -27,740 70.38%
Tax Rate - - - - - - - -
Total Cost 61,651 52,546 59,123 57,963 49,023 36,135 27,740 70.38%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -3.72 -3.32 -3.82 -3.75 -3.18 -2.34 -1.80 62.32%
EPS Diluted -3.72 -3.32 -3.82 -3.75 -3.18 -2.34 -1.80 62.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.